Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.61
+0.66 (4.73%)
At close: Nov 7, 2025, 4:00 PM EST
14.65
+0.04 (0.27%)
After-hours: Nov 7, 2025, 7:56 PM EST

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,9261,2861,2916142,9661,750
Upgrade
Market Cap Growth
90.54%-0.41%110.30%-79.30%69.42%-20.79%
Upgrade
Enterprise Value
1,6531,0251,0472462,6881,367
Upgrade
Last Close Price
14.618.988.994.3222.8713.83
Upgrade
PE Ratio
26.56223.53----
Upgrade
Forward PE
20.8724.06----
Upgrade
PS Ratio
7.535.477.364.5865.0334.93
Upgrade
PB Ratio
5.273.413.421.516.194.29
Upgrade
P/TBV Ratio
5.323.453.461.546.304.39
Upgrade
P/FCF Ratio
16.1029.15----
Upgrade
P/OCF Ratio
16.0428.97----
Upgrade
EV/Sales Ratio
6.224.365.971.8458.9427.27
Upgrade
EV/EBITDA Ratio
16.4432.08----
Upgrade
EV/EBIT Ratio
20.3881.91----
Upgrade
EV/FCF Ratio
13.8223.25----
Upgrade
Debt / Equity Ratio
0.210.210.260.020.020.02
Upgrade
Debt / EBITDA Ratio
0.772.42----
Upgrade
Debt / FCF Ratio
0.651.80----
Upgrade
Asset Turnover
0.490.430.350.260.090.13
Upgrade
Inventory Turnover
1.261.241.982.303.14-
Upgrade
Quick Ratio
5.024.054.868.7611.8412.45
Upgrade
Current Ratio
5.764.575.509.6012.6313.11
Upgrade
Return on Equity (ROE)
20.65%1.52%-19.92%-24.46%-40.81%-29.07%
Upgrade
Return on Assets (ROA)
9.41%1.42%-10.53%-13.74%-22.43%-16.54%
Upgrade
Return on Capital (ROIC)
11.02%1.68%-12.06%-15.46%-24.99%-18.24%
Upgrade
Return on Capital Employed (ROCE)
18.00%2.80%----
Upgrade
Earnings Yield
4.04%0.45%-6.04%-17.62%-6.10%-5.87%
Upgrade
FCF Yield
6.21%3.43%-2.65%-13.00%-5.33%-4.32%
Upgrade
Buyback Yield / Dilution
1.24%-2.07%-0.93%-9.70%-9.20%-27.36%
Upgrade
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q